We are live on
!
Find out more
HFCIV
H&F Corporate Investors VIII Portfolio holdings
AUM
$133M
1-Year Est. Return
24.42%
This Fund
S&P 500
This Quarter
Est. Return
-19.46%
1 Year Est. Return
-24.42%
3 Year Est. Return
-33.78%
5 Year Est. Return
-50.35%
10 Year Est. Return
–
AUM
$166M
AUM Growth
-$120M
(-42%)
Cap. Flow
-$76.3M
Cap. Flow
% of AUM
-45.92%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTEV
Claritev Corp
CTEV
|
+$76.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
STFP
9C
WLG
SWM
LEP
AFP
RA
KCA
H&F Corporate Investors VIII's Q4 2025 Portfolio in Review
As of Q4 2025, H&F Corporate Investors VIII held 1 position worth $166M, down 42% from $286M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
H&F Corporate Investors VIII withdrew a net $76.3M in Q4 2025, reducing 1 holding. Its largest reduction was Claritev Corp, cutting an estimated $76.3M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- H&F Corporate Investors VIII's biggest Q4 2025 reduction was Claritev Corp, cutting an estimated $76.3M.
- H&F Corporate Investors VIII's ten largest holdings make up 100% of its $166M portfolio in Q4 2025.
- H&F Corporate Investors VIII opened 0 new positions and closed 0 in Q4 2025.
- H&F Corporate Investors VIII's portfolio value fell 42% quarter-over-quarter to $166M.
Based on H&F Corporate Investors VIII's 13F filing for Q4 2025, filed 13 Feb 2026.